Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Urinary Incontinence 1Rectal Neoplasms 1Prostatic Neoplasms 1Fecal Incontinence 1

Interventions

Oxaliplatin 49Fluorouracil 45Leucovorin 42Capecitabine 40Irinotecan 31Bevacizumab 31Radiotherapy 24Cetuximab 23Radiation 13Panitumumab 13Folfox protocol 10Surgical Procedures, Operative 9IFL protocol 8Radiotherapy, Intensity-Modulated 6Magnetic Resonance Spectroscopy 6aflibercept 5Immunohistochemistry 5Gene Expression Profiling 5Chemotherapy, Adjuvant 5Fluorodeoxyglucose F18 4Floxuridine 4Celecoxib 4trifluridine tipiracil drug combination 3dehydroftorafur 3XELOX 3Sorafenib 3Ramucirumab 3Neoadjuvant Therapy 3Erlotinib Hydrochloride 3Drug Therapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Rectal Neoplasms × Biofeedback, Psychology × Clear all
NCT00515853 2022-03-07

The Role of Biofeedback in Improving Continence After Anterior Resection

University of Southampton

Phase NA Completed
121 enrolled 9 charts
Gastrointestinal

Fecal Incontinence, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡